Cargando…

The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary)

Detalles Bibliográficos
Autores principales:	Sabnis, Ravindra Bhalchandra, Mulawkar, Prashant Motiram, Joshi, Rohit N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388351/ https://www.ncbi.nlm.nih.gov/pubmed/34465948 http://dx.doi.org/10.4103/iju.iju_121_21

Ejemplares similares

The Urological Society of India guidelines for the evaluation and management of prostate cancer (executive summary)
por: Kumar, Anup, et al.
Publicado: (2022)

Erratum: The Urological Society of India guidelines for the evaluation and management of prostate cancer (executive summary)
Publicado: (2023)

Benign Prostatic Hyperplasia
Publicado: (2015)

Korean clinical practice guideline for benign prostatic hyperplasia
por: Yeo, Jeong Kyun, et al.
Publicado: (2016)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

The Urological Society of India Guidelines for the management of urethral stricture (Executive Summary)
por: Kulkarni, Sanjay B., et al.
Publicado: (2021)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

The authors reply: Korean clinical practice guideline for benign prostatic hyperplasia
por: Yeo, Jeong Kyun, et al.
Publicado: (2016)

Letter to the editor: Korean clinical practice guideline for benign prostatic hyperplasia
por: Jung, Jae Hung, et al.
Publicado: (2016)

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia
por: Rahman, Fakhri, et al.
Publicado: (2019)

The Urological Society of India Guidelines for the management of pediatric urinary tract infection (Executive Summary)
por: Ansari, M. S., et al.
Publicado: (2021)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)
por: Zeng, Xian-Tao, et al.
Publicado: (2022)

The Urological Society of India guidelines for the management of male infertility (Executive Summary)
por: Priyadarshi, Shivam, et al.
Publicado: (2023)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019)

Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia
por: Whish-Wilson, Thomas, et al.
Publicado: (2020)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
por: Ratajczak, Weronika, et al.
Publicado: (2022)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_htbl0nqdu0hoterl5rhn0hv2vb